Allworth Financial LP Has $237,000 Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Allworth Financial LP lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,060 shares of the company’s stock after selling 232 shares during the quarter. Allworth Financial LP’s holdings in GE HealthCare Technologies were worth $237,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of GEHC. Vanguard Group Inc. increased its position in shares of GE HealthCare Technologies by 14.7% in the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock valued at $3,029,917,000 after acquiring an additional 5,693,244 shares during the last quarter. Nuveen Asset Management LLC acquired a new position in GE HealthCare Technologies during the second quarter worth approximately $112,365,000. Trian Fund Management L.P. acquired a new position in GE HealthCare Technologies during the second quarter worth approximately $109,092,000. Ameriprise Financial Inc. increased its position in GE HealthCare Technologies by 84.4% during the third quarter. Ameriprise Financial Inc. now owns 2,668,695 shares of the company’s stock worth $181,578,000 after buying an additional 1,221,436 shares during the last quarter. Finally, Barclays PLC acquired a new position in GE HealthCare Technologies during the second quarter worth approximately $92,462,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 1.8 %

Shares of GEHC stock opened at $85.39 on Thursday. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. The stock has a market cap of $38.97 billion, a P/E ratio of 28.27, a price-to-earnings-growth ratio of 3.05 and a beta of 0.94. The stock has a 50 day simple moving average of $87.69 and a 200 day simple moving average of $77.00. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. During the same period in the previous year, the company posted $1.31 earnings per share. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. On average, research analysts predict that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is presently 3.97%.

Analysts Set New Price Targets

GEHC has been the topic of a number of recent analyst reports. HSBC initiated coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They set a “buy” rating and a $100.00 price target on the stock. Argus boosted their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. Citigroup boosted their price objective on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Mizuho boosted their price objective on GE HealthCare Technologies from $94.00 to $96.00 and gave the stock a “buy” rating in a report on Wednesday, February 7th. Finally, Evercore ISI boosted their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average price target of $93.92.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.